{"name":"Universidade do Vale do Sapucai","slug":"universidade-do-vale-do-sapucai","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Acmella oleracea gel","genericName":"Acmella oleracea gel","slug":"acmella-oleracea-gel","indication":"Other","status":"phase_1"},{"name":"Alpha bisabolol gel","genericName":"Alpha bisabolol gel","slug":"alpha-bisabolol-gel","indication":"Other","status":"phase_1"},{"name":"Alpha bisabolol product","genericName":"Alpha bisabolol product","slug":"alpha-bisabolol-product","indication":"Other","status":"phase_1"},{"name":"Medicinal Plant","genericName":"Medicinal Plant","slug":"medicinal-plant","indication":"Other","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Group Hydroxychloroquine and apixaban","genericName":"Group Hydroxychloroquine and apixaban","slug":"group-hydroxychloroquine-and-apixaban","indication":"Likely autoimmune or inflammatory condition with thrombotic risk (specific indication not publicly detailed for this Phase 3 trial)","status":"phase_3"}]}],"pipeline":[{"name":"Acmella oleracea gel","genericName":"Acmella oleracea gel","slug":"acmella-oleracea-gel","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Alpha bisabolol gel","genericName":"Alpha bisabolol gel","slug":"alpha-bisabolol-gel","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Alpha bisabolol product","genericName":"Alpha bisabolol product","slug":"alpha-bisabolol-product","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Group Hydroxychloroquine and apixaban","genericName":"Group Hydroxychloroquine and apixaban","slug":"group-hydroxychloroquine-and-apixaban","phase":"phase_3","mechanism":"This combination pairs hydroxychloroquine, an immunomodulator that reduces inflammation and autoimmune activity, with apixaban, an anticoagulant that inhibits Factor Xa to prevent thrombosis.","indications":["Likely autoimmune or inflammatory condition with thrombotic risk (specific indication not publicly detailed for this Phase 3 trial)"],"catalyst":""},{"name":"Medicinal Plant","genericName":"Medicinal Plant","slug":"medicinal-plant","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":3,"phase_3":1,"phase_2":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}